Results 51 to 60 of about 6,145 (277)

Oral Midodrine as an Adjunct in Rapid Weaning of Intravenous Vasopressor Support in Spinal Cord Injury

open access: yesAsian Journal of Neurosurgery, 2023
Background  Majority of acute cervical spinal cord injury end up requiring long-term stay in intensive care unit (ICU). During the initial few days after spinal cord injury, most patients are hemodynamically unstable requiring intravenous vasopressors ...
Arunkumar Sekar   +5 more
semanticscholar   +1 more source

Efficacy of atomoxetine versus midodrine for neurogenic orthostatic hypotension

open access: yesAnnals of Clinical and Translational Neurology, 2020
Objective The efficacy and safety of 1‐month atomoxetine and midodrine therapies were compared. Three‐month atomoxetine and combination therapies were investigated for additional benefits.
Jung‐Ick Byun   +13 more
doaj   +1 more source

Review of adjunctive midodrine to facilitate weaning intravenous vasopressors in critically ill patients [PDF]

open access: yes, 2020
Background/Purpose: Intravenous (IV) vasopressor agents are mainstay therapy for the management of refractory hypotension in critically ill patients in the intensive care unit (ICU).
Clarke, Heidi   +4 more
core   +1 more source

Management of ascites in patients with cirrhosis: An update [PDF]

open access: yes, 2021
Ascites represents a critical event in the natural history of liver cirrhosis. From a prognostic perspective, its occurrence marks the transition from the compensated to the decompensated stage of the disease, leading to an abrupt worsening of patients ...
Caraceni P.   +3 more
core   +1 more source

Midodrine treatment for chronic fatigue syndrome [PDF]

open access: yesPostgraduate Medical Journal, 2004
Abstract The long term results of midodrine treatment in a patient having debilitating chronic fatigue syndrome (CFS) are reported. Midodrine treatment, directed at the autonomic nervous system, resulted in correction of the dysautonomia followed by improvement of fatigue.
J E Naschitz   +3 more
openaire   +3 more sources

Treatment of Vasovagal Syncope Associated with Asystole: Literature Review and Case Report of Long-term Follow-up

open access: yesРациональная фармакотерапия в кардиологии, 2021
Vasovagal syncope (VVS) can occur in every third of human population. Clinical symptoms of VVS areas a result of arterial hypotension with critical global cerebral hypoperfusion due to vasodilatation and bradicardia.
A. V. Pevzner   +3 more
doaj   +1 more source

Efficacy of Pharmacologic Treatment for Orthostatic Hypotension in the Elderly Population [PDF]

open access: yes, 2021
The purpose of this literature review is to determine the efficacy and safety of pharmacologic treatments for orthostatic hypotension (OH), with an emphasis on researching the elderly population.
Moeller, Abigail
core   +2 more sources

Fludrocortisone Is Associated With a Higher Risk of All‐Cause Hospitalizations Compared With Midodrine in Patients With Orthostatic Hypotension

open access: yesJournal of the American Heart Association: Cardiovascular and Cerebrovascular Disease, 2017
BackgroundOrthostatic hypotension causes ≈80 000 hospitalizations per year in the United States. Treatments for orthostatic hypotension include fludrocortisone, a mineralocorticoid analog that promotes sodium reabsorption; and midodrine, an α‐1 ...
Carlos G. Grijalva   +3 more
doaj   +1 more source

Midodrine: a role in the management of neurocardiogenic syncope [PDF]

open access: yesHeart, 1998
To determine the benefit of midodrine, an alpha agonist, on symptom frequency and haemodynamic responses during head up tilt in patients with neurocardiogenic syncope.Cardiovascular investigation unit (a secondary and tertiary referral centre for the investigation and management of syncope).16 outpatients (mean (SD) age 56 (18) years; five men) with ...
J J Gilroy   +3 more
openaire   +3 more sources

Midodrine therapy for vasopressor dependent shock in the intensive care unit: a protocol for a systematic review and meta-analysis

open access: yesBMJ Open, 2022
Introduction Intensive care unit (ICU) lengths of stay are modified by ongoing need for haemodynamic support in critically ill patients. This is most commonly provided by intravenous vasopressor therapy.
Oleksa G Rewa   +14 more
doaj   +1 more source

Home - About - Disclaimer - Privacy